Top Markets
#1 Derive Derive +31.47%
#2 Audiera Audiera +14.41%
#3 Palladium Network Palladium Network +12.66%
#4 The Bitcoin Bull The Bitcoin Bull +10.64%
#5 Cross Cross +10.45%
#6 Gama Token Gama Token +9.20%
#7 Geodnet Geodnet +8.35%
#8 Humanity Humanity +7.62%
#9 Cap Cap +7.48%
#10 Starpower Starpower +7.47%
Coin of the day
Derive Derive
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Dogwood Therapeutics, Inc. Dogwood Therapeutics, Inc.

Dogwood Therapeutics, Inc.

DWTX
Rang in aandelen #35719
Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to... Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to creating innovative antiviral treatments. Their primary goal is to address illnesses that stem from atypical immune reactions provoked by viral infections. Its leading therapeutic candidate, IMC-1, is a precise fixed-dose combination of famciclovir and celecoxib, engineered to combat fibromyalgia. Additionally, the company is advancing IMC-2, which blends valacyclovir and celecoxib, aiming to alleviate the array of symptoms linked to long COVID, including persistent fatigue, sleep disturbances, cognitive issues, pain, autonomic dysfunction, and anxiety. Previously operating as Virios Therapeutics, Inc., the organization adopted the name Dogwood Therapeutics, Inc. in October 2024. Established in 2012, the company maintains its main office in Alpharetta, Georgia.
Aandeelprijs
$1.84
Laatst gesynchroniseerd: 2026-08-11
Marktkapitalisatie
$3.51M
Verandering (1 dag)
0.46%
Verandering (1 jaar)
-62.71%
Land
US
Handel Dogwood Therapeutics, Inc. (DWTX)

Categorie

Healthcare
EPS voor Dogwood Therapeutics, Inc. (DWTX)
EPS per 2026 TTM: 0
Volgens de laatste financiële rapporten en de aandelenkoers van Dogwood Therapeutics, Inc. is de huidige EPS van het bedrijf (TTM) 0. Eind 2026 had het bedrijf een EPS van 0, gelijk aan de EPS van 2026 die 0 bedroeg.
EPS-geschiedenis van Dogwood Therapeutics, Inc. van 2026 tot 2026
EPS aan het einde van elk jaar
Jaar EPS Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
EPS van vergelijkbare bedrijven of concurrenten
Bedrijf EPS EPS-verschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE